Positive trends in the annual result testifies to an important turning point for DanBred. After a year of major changes, the company delivers significant progress in 2023. Revenue has increased by more than 15 % to DKK 1.1 billion. EBITDA is at DKK 34 million. In early summer 2024, the company will move to a […]
Join our list and get valuable insights and practical knowledge directly in your mailbox.
We can help you transition to DanBred genetics, technical services, transport and more. Book a time with us, and we will call you when it suits you.
Do you think DanBred might be the right choice for you or someone you know? Click below to get in on the progress.
